ArticleOPEN ACCESS

Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout

Rheumatology (United Kingdom)
DOI: 10.1093/rheumatology/keae210
1Citations
Citations of this article
1Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Zhao, S. S., Cuthbertson, D. J., & Alam, U. (2024, October 1). Human genetic evidence supports fibroblast growth factor 21 as a novel therapeutic target for gout. Rheumatology (United Kingdom). Oxford University Press. https://doi.org/10.1093/rheumatology/keae210

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free